Cargando…
Reduced mortality from KPC-K.pneumoniae bloodstream infection in high-risk patients with hematological malignancies colonized by KPC-K.pneumoniae
BACKGROUND: KPC-K.pneumoniae bloodstream infection (KPC-KpBSI) mortality rate in patients with hematological malignancies is reported about 60%. The initial treatment active against KPC-K.pneumoniae is crucial for survival and KPC-K.pneumoniae rectal colonization usually precedes KPC-KpBSI. We evalu...
Autores principales: | Micozzi, Alessandra, Gentile, Giuseppe, Santilli, Stefania, Minotti, Clara, Capria, Saveria, Moleti, Maria Luisa, Barberi, Walter, Cartoni, Claudio, Trisolini, Silvia Maria, Testi, Anna Maria, Iori, Anna Paola, Bucaneve, Giampaolo, Foà, Robin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524821/ https://www.ncbi.nlm.nih.gov/pubmed/34666695 http://dx.doi.org/10.1186/s12879-021-06747-8 |
Ejemplares similares
-
Benefits and Safety of Empiric Antibiotic Treatment Active Against KPC-K. pneumoniae in Febrile Neutropenic Patients with Acute Leukemia Who are Colonized with KPC-K. pneumoniae. A 7-Years Retrospective Observational Cohort Study
por: Micozzi, Alessandra, et al.
Publicado: (2023) -
Carbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias
por: Micozzi, Alessandra, et al.
Publicado: (2017) -
Reduced transmission of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae (KPC-KP) in patients with haematological malignancies hospitalized in an Italian hospital during the COVID-19 pandemic
por: Micozzi, Alessandra, et al.
Publicado: (2021) -
Cost-Effectiveness of Short Course of Ceftazidime/Avibactam for K. pneumoniae-KPC Bloodstream Infections in Italy
por: De Benedetto, Ilaria, et al.
Publicado: (2023) -
Has Hematopoietic Stem Cell Transplantation a Role in the Treatment of Children and Adolescents with Acute Promyelocytic Leukemia?
por: Testi, Anna Maria, et al.
Publicado: (2022)